Dr. Miller is founder of Indevric Consulting, LLC. Indevric provides consulting services to pharmaceutical and biotech companies, specializing in providing regulatory guidance for small to midsize companies.
She is a regulatory professional with over 20 years of industry experience providing regulatory leadership for small molecules and biologics. Her therapeutic areas of expertise include oncology, ophthalmology, inflammation, neurology, pulmonary, and rare diseases. Her regulatory strategies have resulted in successful filings of Orphan Drug Designations, INDs, CTAs, and NDA/BLAs. She tailors her strategic guidance to fit the stage of development and has provided regulatory leadership for drug development programs that are preclinical through marketing applications. She has led cross-functional teams in Health Authority interactions to develop innovative and efficient development pathways to achieve regulatory objectives.
Dr. Miller has a doctorate in Tumor Cell Biology from Northwestern University and a B.S. in Genetic Engineering from Cedar Crest College.
Copyright © 2024 Indevric Consulting - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.